1. Home
  2. VIR vs RMIX Comparison

VIR vs RMIX Comparison

Compare VIR & RMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$11.31

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Suncrete Inc. Class A Common Stock

RMIX

Suncrete Inc. Class A Common Stock

N/A

Current Price

$17.86

Market Cap

1.4B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VIR
RMIX
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
VIR
RMIX
Price
$11.31
$17.86
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.43
N/A
AVG Volume (30 Days)
1.5M
253.4K
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
17.49
N/A
EPS
N/A
N/A
Revenue
$68,556,000.00
N/A
Revenue This Year
$270.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$16.59
52 Week High
$11.66
$25.50

Technical Indicators

Market Signals
Indicator
VIR
RMIX
Relative Strength Index (RSI) 73.93 44.82
Support Level $8.43 $17.00
Resistance Level $11.66 $18.81
Average True Range (ATR) 0.51 1.03
MACD 0.25 0.03
Stochastic Oscillator 93.86 29.17

Price Performance

Historical Comparison
VIR
RMIX

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About RMIX Suncrete Inc. Class A Common Stock

Suncrete Inc is a ready-mix concrete logistics and distribution platform operating across Oklahoma and Arkansas. Ready-mix concrete is a crucial building material that is used in the vast majority of infrastructure, commercial and residential construction projects. The company's ready-mix concrete business engages principally in the precise formulation, efficient production and on-time delivery of ready-mix concrete to the customers' job sites. It serves substantially all end markets of the construction industry in the select geographic markets. The company earns revenue prominently from the production and delivery of ready-mix concrete, with the majority revenue generated from orders under master purchase agreements or through direct sales to third-party contractors and suppliers.

Share on Social Networks: